Stock Screener App

Gratuito -

Installare

34.96

10.53% 3.3402

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TEVA Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Teva Pharmaceutical Industries Ltd Adr Borsa (TEVA) Ultime notizie

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva's Pivot to Growth Strategy - Benzinga

Intel Upgraded, Toyota Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Dermatomycoses Market Report 2025-2035, Profiles of Prominent Players - GlobeNewswire Inc.

Is It Too Late To Reassess Teva (TEVA) After Its 118.5% One-Year Surge? - Sahm

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After The Home Ground Schizophrenia Platform Launch - Sahm

Teva- Pharmaceutical Industries Ltd.ADR (TEVA) News, Articles, Events & Latest Updates - Stocktwits

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners - Sahm

Teva Pharmaceutical (ADR) stock (US88162G1031): Why generic drug execution is suddenly worth a close - AD HOC NEWS

Does Biosimilar Wins in Osteoporosis and Allergy Care Change The Bull Case For Teva (TEVA)? - Sahm

A Look At Teva Pharmaceutical Industries (TEVA) Valuation After Recent Biosimilar Regulatory Milestones - Sahm

Target Upgraded, Robinhood Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

How Investors Are Reacting To Teva (TEVA) Advancing Its Biosimilar Pipeline With New FDA and EMA Milestones - Sahm

Assessing Teva Pharmaceutical Industries (TEVA) Valuation After New Biosimilar Approvals And Pipeline Progress - Sahm

Missile Strike Tests Teva Supply Resilience And Biosimilar Growth Plans - Sahm

Price to sales ratio of Teva Pharmaceutical Industries Limited Sponsored ADR – BSESOF:TEV - TradingView

Teva’s New Biosimilars Test Growth Plan And Earnings Reshaping Potential - Sahm

ETFs Investing in Teva Pharmaceutical Industries Limited Sponsored ADR Stocks - TradingView

How Investors May Respond To Teva (TEVA) Advancing TEV ‘325 In Biologics For Inflammatory Diseases - Sahm

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Recent Share Price Weakness - Sahm

TEVA Stock Price, Quote & Chart | TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) - ChartMill

Teva Pharmaceutical Industries Limited Sponsored ADR Trade Ideas — LS:883035 - TradingView

Teva Releases Q1 2026 Aide Memoire - Sahm

Will Teva’s (TEVA) Olanzapine LAI Milestone and Legal Win Change Its Innovation-Led Narrative? - Sahm

Tesla Upgraded, Super Micro Computer Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

How Teva’s Blackstone-Backed ‘Pivot to Growth’ Strategy Could Reshape Teva Pharmaceutical Industries (TEVA) Investors - Sahm

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Pivot To Growth Update At Leerink Conference - Sahm

Teva Blackstone Duvakitug Deal Tests Growth Story And Concentration Risk - Sahm

Teva Drug Updates Support Branded Growth Story And Valuation Upside Potential - Sahm

What's Driving the Market Sentiment Around Teva Pharmaceutical Industries Ltd? - Sahm

Duvakitug IBD Data and TEV-749 Filing Might Change The Case For Investing In Teva (TEVA) - Sahm

Teva to Present at the Upcoming Investor Conferences in March - Sahm

J&J Stock Up 38% in 6 Months: Should You Buy, Sell or Hold? - Finviz

Where is Teva Pharmaceutical Industries Limited (TEVA) Headed? - Finviz

Corcept's Q4 Earnings and Revenues Fall Short of Estimates - Finviz

FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application - Sahm

Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Its Strong Recent Share Price Momentum - Sahm

Truist Boosts Teva (TEVA) Stock Target Amid Pipeline Growth Opportunities - Finviz

Corcept Therapeutics Stock Plunges As Court Clears Teva Generic - Sahm

Goldman Sachs See Teva Pharmaceutical Industries Limited (TEVA) Driving Double-Digit Earnings Growth Through 2026 - Finviz

Teva Pharmaceutical Industries Ltd (TEVA) Stock Price, Trades & News - GuruFocus

Teva’s Duvakitug Data Puts Ulcerative Colitis And Crohn’s Bet In Focus - Sahm

Should You Invest in Teva Pharmaceutical (TEVA), Here's What the Street Has to Say - Finviz

HLN

$9.255

2.32%

ZTS

$113.11

3.01%

TAK

$16.30

0.70%

UTHR

$571.61

0.43%

VTRS

$14.85

0.34%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters